ASCLETIS-B (01672) spent HK$15.9275 million on December 3 to repurchase 1.306 million shares.
Ge Li Pharmaceutical-B (01672) announced that on December 3, 2025, the company spent HK $15.9275 million to repurchase 1.306 million shares, with a repurchase price of HK $11.68-12.48 per share.
ASCLETIS-B (01672) announced on December 3, 2025, that the company will spend 15,927,500 Hong Kong dollars to repurchase 1,306,000 shares, with a repurchase price ranging from 11.68 to 12.48 Hong Kong dollars per share.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


